Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Scandinavian Cardiovascular Journal : SCJ|August 16, 2005
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002Gunnar H Gislason, Steen Z Abildstrom, Jeppe N Rasmussen, et al.
Diabetes, Obesity & Metabolism|July 10, 2020
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trialsSubodh Verma, Stephen C Bain, Julie Broe Honoré, et al.
Diabetes Care|January 28, 2021
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER TrialFrederik Persson, Stephen C Bain, Ofri Mosenzon, et al.
Heart (British Cardiac Society)|November 6, 2010
Influence of distance from home to invasive centre on invasive treatment after acute coronary syndrome: a nationwide study of 24 910 patientsAnders Hvelplund, Søren Galatius, Mette Madsen, et al.
Cardiology|July 10, 2008
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarctionSøren Skøtt Andersen, Morten Lock Hansen, Gunnar H Gislason, et al.
Diabetes, Obesity & Metabolism|July 4, 2020
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialOfri Mosenzon, Stephen C Bain, Hiddo J L Heerspink, et al.
Circulation|April 2, 2008
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million peopleTina Ken Schramm, Gunnar H Gislason, Lars Køber, et al.
European Heart Journal|November 26, 2009
Women with acute coronary syndrome are less invasively examined and subsequently less treated than menAnders Hvelplund, Søren Galatius, Mette Madsen, et al.
American Heart Journal|June 3, 2008
Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trialAnn-Dorthe Olsen Zwisler, Anne Merete Boas Soja, Søren Rasmussen, et al.
Circulation. Cardiovascular Quality and Outcomes|June 10, 2010
Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individualsEmil Loldrup Fosbøl, Fredrik Folke, Søren Jacobsen, et al.
Pageof 11